ECL · Ecolab Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.07B | - | $4.17B | $4.03B | $3.69B | - | $4.00B | $3.99B | $3.75B | - |
| Cost of Revenue | $2.30B | - | $2.30B | $2.22B | $2.06B | - | $2.26B | $2.24B | $2.13B | - |
| Gross Profit | $1.77B | - | $1.87B | $1.80B | $1.63B | - | $1.74B | $1.74B | $1.62B | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $1.10B | - | $1.08B | $1.07B | $1.05B | - | $1.02B | $1.08B | $1.08B | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $180.50M | - | - | - | $161.20M | - | - | - | $157.00M | - |
| Operating Income | $622.00M | - | $760.20M | $710.10M | $555.30M | - | $1.04B | $656.90M | $517.90M | - |
| Interest Expense | $77.30M | - | $74.60M | $76.20M | $72.60M | - | $86.40M | $80.20M | $94.50M | - |
| Income Tax | $121.50M | - | $128.00M | $131.40M | $103.50M | - | $246.50M | $95.70M | $42.30M | - |
| Net Income | $432.60M | - | $585.00M | $524.20M | $402.50M | - | $736.50M | $490.90M | $412.10M | - |
| EPS - Basic | $1.53 | - | $2.06 | $1.85 | $1.42 | - | $2.60 | $1.72 | $1.44 | - |
| EPS - Diluted | $1.52 | - | $2.05 | $1.84 | $1.41 | - | $2.58 | $1.71 | $1.43 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $519.80M | $646.20M | $1.96B | $1.92B | $1.16B | $1.26B | $1.26B | $384.00M | $479.90M | $919.50M |
| Accounts Receivable | $3.28B | $3.25B | $3.11B | $3.06B | $2.86B | $2.87B | $2.88B | $2.88B | $2.79B | $2.83B |
| Inventory | $1.57B | $1.49B | $1.53B | $1.57B | $1.55B | $1.46B | $1.57B | $1.51B | $1.57B | $1.50B |
| Accounts Payable | $2.05B | $2.07B | $1.87B | $1.88B | $1.77B | $1.81B | $1.81B | $1.69B | $1.61B | $1.57B |
| Current Assets | $6.04B | $5.96B | $7.11B | $7.08B | $6.08B | $6.03B | $6.12B | $5.75B | $5.21B | $5.64B |
| Total Assets | $25.04B | $24.70B | $23.90B | $23.74B | $22.37B | $22.39B | $22.10B | $21.46B | $21.30B | $21.85B |
| Current Liabilities | $6.10B | $5.53B | $4.19B | $4.91B | $4.61B | $4.79B | $4.71B | $3.85B | $3.70B | $4.35B |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $15.01B | $14.89B | $14.14B | $14.39B | $13.46B | $13.60B | $13.53B | $13.15B | $13.07B | $13.77B |
| Stockholders' Equity | $10.00B | $9.77B | $9.72B | $9.32B | $8.88B | $8.76B | $8.55B | $8.29B | $8.21B | $8.04B |
| Retained Earnings | $13.06B | $12.83B | $12.48B | $12.08B | $11.74B | $11.52B | $11.23B | $10.65B | $10.32B | $10.08B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $445.90M | - | - | - | $369.40M | - | - | - | $649.40M | - |
| Investing Cash Flow | ($355.50M) | - | - | - | ($224.00M) | - | - | - | ($201.00M) | - |
| Financing Cash Flow | ($225.80M) | - | - | - | ($241.60M) | - | - | - | ($889.30M) | - |
| CapEx | $348.50M | - | - | - | $237.90M | - | - | - | $201.50M | - |
| Free Cash Flow | $97.40M | - | - | - | $131.50M | - | - | - | $447.90M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 43.6% | - | 44.8% | 44.8% | 44.2% | - | 43.4% | 43.8% | 43.3% | - |
| Operating margin | 15.3% | - | 18.3% | 17.6% | 15.0% | - | 26.1% | 16.5% | 13.8% | - |
| EBITDA margin | 19.7% | - | - | - | 19.4% | - | - | - | 18.0% | - |
| Net margin | 10.6% | - | 14.0% | 13.0% | 10.9% | - | 18.4% | 12.3% | 11.0% | - |
| Free cash flow margin | 2.4% | - | - | - | 3.6% | - | - | - | 11.9% | - |
| FCF / Net income | 0.23 | - | - | - | 0.33 | - | - | - | 1.09 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 27.1% | - | 25.9% | 26.5% | 28.4% | - | 25.6% | 27.0% | 28.7% | - |
| Effective tax rate | 21.9% | - | 18.0% | 20.0% | 20.5% | - | 25.1% | 16.3% | 9.3% | - |
| Return on assets | 1.7% | - | 2.4% | 2.2% | 1.8% | - | 3.3% | 2.3% | 1.9% | - |
| Return on equity | 4.3% | - | 6.0% | 5.6% | 4.5% | - | 8.6% | 5.9% | 5.0% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.99 | 1.08 | 1.70 | 1.44 | 1.32 | 1.26 | 1.30 | 1.50 | 1.41 | 1.30 |
| Quick ratio | 0.73 | 0.81 | 1.33 | 1.12 | 0.98 | 0.95 | 0.97 | 1.10 | 0.99 | 0.95 |
| Cash ratio | 0.09 | 0.12 | 0.47 | 0.39 | 0.25 | 0.26 | 0.27 | 0.10 | 0.13 | 0.21 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 8.0x | - | 10.2x | 9.3x | 7.6x | - | 12.1x | 8.2x | 5.5x | - |
| Equity multiplier | 2.50 | 2.53 | 2.46 | 2.55 | 2.52 | 2.56 | 2.59 | 2.59 | 2.60 | 2.72 |
| Liabilities / Assets | 0.60 | 0.60 | 0.59 | 0.61 | 0.60 | 0.61 | 0.61 | 0.61 | 0.61 | 0.63 |
| Efficiency | ||||||||||
| Asset turnover | 0.16 | - | 0.17 | 0.17 | 0.17 | - | 0.18 | 0.19 | 0.18 | - |
| Inventory turnover | 1.46 | - | 1.50 | 1.42 | 1.33 | - | 1.44 | 1.49 | 1.36 | - |
| Days sales outstanding | 294d | - | 273d | 277d | 282d | - | 263d | 263d | 271d | - |
| Days inventory outstanding | 250d | - | 244d | 258d | 274d | - | 254d | 245d | 269d | - |
| Days payable outstanding | 327d | - | 297d | 309d | 313d | - | 293d | 275d | 276d | - |
| Cash conversion cycle | 218d | - | 220d | 226d | 244d | - | 224d | 233d | 264d | - |
| Valuation | ||||||||||
| P / E | 175.0x | - | 133.6x | 146.4x | 179.8x | - | 99.0x | 139.2x | 161.5x | - |
| P / B | 7.5x | - | 8.0x | 8.3x | 8.1x | - | 8.5x | 8.2x | 8.1x | - |
| P / S | 18.6x | - | 18.8x | 19.1x | 19.6x | - | 18.3x | 17.1x | 17.7x | - |
| EV / EBITDA | 93.4x | - | - | - | 99.3x | - | - | - | 97.8x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 10.0% | - | 4.2% | 1.0% | -1.5% | - | 1.0% | 3.5% | 5.0% | - |
| Revenue CAGR (3y) | 4.4% | - | 4.3% | 4.0% | 4.2% | - | 6.4% | 8.0% | 9.2% | - |
| Revenue CAGR (5y) | 7.1% | - | 6.7% | 8.4% | 0.6% | - | 0.9% | 1.2% | 1.4% | - |
| Gross profit growth (YoY) | 8.3% | - | 7.4% | 3.3% | 0.7% | - | 6.7% | 15.0% | 18.8% | - |
| Operating income growth (YoY) | 12.0% | - | -27.2% | 8.1% | 7.2% | - | 84.6% | 35.5% | 47.3% | - |
| Net income growth (YoY) | 7.5% | - | -20.6% | 6.8% | -2.3% | - | 82.3% | 48.9% | 76.6% | - |
| EPS growth (YoY) | 7.8% | - | -20.5% | 7.6% | -1.4% | - | 83.0% | 48.7% | 74.4% | - |
| EPS CAGR (3y) | 22.8% | - | 19.2% | 19.4% | 33.0% | - | 32.1% | 16.6% | 28.8% | - |
| EPS CAGR (5y) | 17.8% | - | 19.3% | - | 7.8% | - | 10.2% | 6.3% | 7.2% | - |
| FCF growth (YoY) | -25.9% | - | - | - | -70.6% | - | - | - | 1728.2% | - |
| FCF CAGR (5y) | -12.8% | - | - | - | -9.0% | - | - | - | 18.6% | - |
| Book value growth (YoY) | 12.7% | 11.6% | 13.7% | 12.5% | 8.2% | 8.9% | 9.6% | 9.7% | 11.7% | 11.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$16.08B totalWater Services$7.98B · 49.6%
Global Institutional$6.10B · 38.0%
Global Pest Elimination$1.25B · 7.8%
Global Healthcare And Life Sciences$747.90M · 4.7%
Product / service
$16.08B totalProduct And Equipment$12.62B · 78.5%
Service And Lease$3.46B · 21.5%
Geographic
$7.98B totalUS$3.42B · 42.8%
Europe$1.66B · 20.8%
Asia Pacific$945.70M · 11.8%
Latin America$816.70M · 10.2%
India Middle East And Africa$501.10M · 6.3%
CN$410.40M · 5.1%
CA$232.30M · 2.9%
Peer comparison
Same SIC group: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Comparing ECOLAB INC. against the 5 most active filers in the same SIC group.
Dividends
$2.76/share trailing 12 months · +13.1% YoY
| Ex-date | Per share |
|---|---|
| Mar 17, 2026 | $0.7300 |
| Dec 16, 2025 | $0.7300 |
| Sep 16, 2025 | $0.6500 |
| Jun 17, 2025 | $0.6500 |
| Mar 18, 2025 | $0.6500 |
| Dec 17, 2024 | $0.6500 |
| Sep 17, 2024 | $0.5700 |
| Jun 18, 2024 | $0.5700 |
| Mar 18, 2024 | $0.5700 |
| Dec 18, 2023 | $0.5700 |
| Sep 18, 2023 | $0.5300 |
| Jun 16, 2023 | $0.5300 |
| Mar 20, 2023 | $0.5300 |
| Dec 19, 2022 | $0.5300 |
| Sep 19, 2022 | $0.5100 |
| Jun 17, 2022 | $0.5100 |
| Mar 14, 2022 | $0.5100 |
| Dec 13, 2021 | $0.5100 |
| Sep 13, 2021 | $0.4800 |
| Jun 14, 2021 | $0.4800 |
| Mar 15, 2021 | $0.4800 |
| Dec 14, 2020 | $0.4800 |
| Sep 14, 2020 | $0.4700 |
| Jun 15, 2020 | $0.4700 |